Eledon Pharmaceuticals Inc (NASDAQ:ELDN)
| 3.32 Delayed Data As of Jan 26 |  0.00 / 0.00%Today’s Change | 2.03 Today|||52-Week Range 4.39 | +45.61% Year-to-Date |
Latest ELDN News | Press Releases
No recent news for Eledon Pharmaceuticals Inc.
Today’s Trading
| Previous close | 3.32 |
| Today’s open | 3.32 |
| Day’s range | 3.32 - 3.32 |
| Volume | 100 |
| Average volume (3 months) | 19,202 |
| Market cap | $46.1M |
Data as of 3:58pm ET, 01/26/2023
Growth & Valuation
| Earnings growth (last year) | +85.18% |
| Earnings growth (this year) | -12.77% |
| Earnings growth (next 5 years) | -65.71% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.29 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LPCNLipocine Inc | +0.01 | +2.60% |
| CRDLCardiol Therapeutics... | +0.02 | +2.70% |
| ABEOAbeona Therapeutics ... | +0.01 | +0.38% |
| AQSTAquestive Therapeuti... | -0.01 | -0.57% |
Data as of 3:59pm ET, 01/27/2023
Financials
| Next reporting date | March 29, 2023 |
| EPS forecast (this quarter) | -$0.62 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$34.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
